CRBP compared with NSPR: revenue, margins and what each company keeps, and the suppliers and customers both name

CRBPCorbus Pharmaceuticals Holdings, Inc.

Mkt capRevenueRevenue

NSPRInspireMD, Inc.

Mkt capRevenueRevenue

Compare

CRBPCorbus Pharmaceuticals Holdings, Inc.

NSPRInspireMD, Inc.

Price

Mkt cap

Revenue

Revenue flow Supply chain Price Co-movers Event sensitivity Earnings history

Save comparison

Earnings history

News Findings Companies A–Z Pricing Methodology Sources Corrections About Terms

Not investment advice. Not a broker-dealer. Indices shown as ETF proxies. Supply-chain data CC BY 4.0; market data not redistributable.

Listed on One’s Vibe · live-checked · Oct ’26

Desk News Calendar Saved

Earnings history

last 4 reports each · paired by recencyMethod ›

CRBP1 of 4 reports

0 of 1at or beyond implied

Reportimpliedrealized× implied

Q2 FY26±15.6%▲+1.78%×0.12

NSPR1 of 4 reports

Reportimpliedrealized× implied

Q2 FY26—▼−10.44%—

= impliedCRBP realized, solidNSPR realized, hatchedOne scale, both sides: full bar = 16%× = |realized| ÷ impliedSource: market data

CRBPCorbus Pharmaceuticals Holdings, Inc.

4.20▼−0.43%· post 4.20

Mkt cap$81.6MRevenue$1MQ2 FY26Revenue$6MFY25

NSPRInspireMD, Inc.

0.45▼−0.33%· post 0.45

ClosedOct 30 '26

Mkt cap$20.9MRevenue$2MQ2 FY26Revenue$9MFY25

Compare

ClosedOct 30 '26

CRBPCorbus Pharmaceuticals Holdings, Inc.

NSPRInspireMD, Inc.

4.20▼−0.43%post 4.20

Price

0.45▼−0.33%post 0.45

$81.6M

Mkt cap

$20.9M

Q2 FY26$1M

Revenue

$2MQ2 FY26

FY25$6M

Revenue

$9MFY25

CRBP4.20▼−0.43%vsNSPR0.45▼−0.33%ClosedOct 30 '26